[OX-C Treatment] technology
Inspired by regenerative medicine, the new [OX-C Treatment] technology acts on the skin's oxygen transporters to stimulate regeneration and triple⁴ collagen I production.
Face and Neck Serum - High-Performance Anti-Aging Correction - Wrinkles and Firmness
AFTER 40 YEARS OF RESEARCH, THE PIONEER IN MOTHER CELLS Inspired by regenerative medicine, Dior Capture has reinvented the iconic serum with a formula that delivers results in as little as 7 days: wrinkles are visibly replenished, skin appears firmer and the face looks younger. This face serum encapsulates OX-C Treatment with regenerating and replenishing powers: this technology promotes skin regeneration and triples collagen production¹ by acting on oxygen transport. Using a pro-penetrating exo-liposome, a patented² double vectorization system, OX-C Treatment is deeply and continuously diffused for 8 hours.³ Dior Capture Le Sérum is formulated with 97% natural-origin ingredients.⁴ ¹ In vitro test on ingredients. ² Patent pending FR3144515. ³ Ex vivo test on ingredients. ⁴ Amount calculated based on the ISO 16128-1 and ISO 16128-2 standard. Water percentage included. The remaining 3% contribute to the formula’s performance, sensoriality and stability.
In 7 days
women report that their skin is twice as firmer¹After 1 month
skin is visibly five times smoother and revitalized²After 2 months
skin is 50% more elastic and 59% more radiant³Inspired by regenerative medicine, the new [OX-C Treatment] technology acts on the skin's oxygen transporters to stimulate regeneration and triple⁴ collagen I production.
Patented⁵ double vectorization enables deep, prolonged diffusion of ingredients for 8 hours.⁶
Dior Science has chosen a new lily extract that has been shown to boost epidermal regeneration on mother cells.
Application
Dior Science
"By transporting oxygen to the right place, the [OX-C Treatment] technology boosts the skin cells’ ability to produce collagen."
Dr. Patricia Ogilvie - Dior Reverse Aging board-certified dermatologist
With Charlize Theron
¹ Self-evaluation - 49 women. Comparison between T0 and T7.
² Clinical test conducted by a dermatologist - 49 women - Comparison between T0 and T28.
³ Clinical test conducted by a dermatologist, 34 women at T56.
⁴ In vitro test on ingredient.
⁵ Patent application FR3144515 pending.
⁶ Ex vivo test on ingredients.